Global Sleep Apnea Diagnostic System Market is Expected to be Worth US$ 14,639.7 Mn, By The End of 2027

Sleep Apnea Diagnostic System
Sleep Apnea Diagnostic System


Polysomnography (PSG) devices, screening devices, and actigraphy monitoring devices are examples of sleep apnea diagnostic systems. Polysomnography is a type of sleep study that is used to diagnose a variety of sleep disorders. The device records brain waves, blood oxygen levels, heart rate, breathing, and eye and leg movements, among other things.

Working in shifts and stressful working environments cause sleep apnea, and various technological advancements in Sleep Apnea Diagnostic System Market are driving the growth of the global sleep apnea diagnostics market. However, the high cost of sleep apnea diagnostics and a lack of awareness about sleep apnea are limiting the market's growth. Untapped markets in developing economies, on the other hand, are expected to present lucrative opportunities during the forecast period.

The rising prevalence of sleep apnea will be a major factor driving the global Sleep Apnea Diagnostic System Market. According to a study published in July 2019 titled "Estimation of the global prevalence and burden of obstructive sleep apnea: a literature-based analysis," 936 million adults aged 30–69 years have mild to severe obstructive sleep apnea and 425 million adults aged 30–69 years have moderate to severe obstructive sleep apnea globally.

Furthermore, the high prevalence of cardiovascular disease (CVD) is expected to boost market growth. According to the American Heart Association's Heart Disease and Stroke Statistics 2018, approximately 92.1 million adults in the United States suffer from CVD or stroke-related complications. In terms of volume, North America dominated the global sleep apnea diagnostic system market in 2019, accounting for 53.5 percent of the market, followed by Asia Pacific.

The Coronavirus (COVID-19) was discovered in Wuhan, Hubei Province, China. The disease is caused by a virus called SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which is transmitted from person to person. Restrictions on the cross-border trade of pharmaceutical ingredients and products disrupted supply chains. COVID 19 is also an infectious disease that causes flu-like symptoms such as fever, cough, and difficulty breathing. The COVID-19 pandemic has impacted the most critical areas of the Sleep Apnea Diagnostic System Market by disrupting clinical trials and drug supply to patients.

Comments

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

Global Report on LED Driver Market for the Forecast Period 2023-2030